What question did this study set out to answer?

The aim is to investigate rapid antimicrobial susceptibility testing directly from positive blood cultures in patients with sepsis.

June 6, 2026The AnalystOpen Access

Rapid antimicrobial susceptibility testing direct from positive blood cultures

View Full Paper

Ask AI

Bookmark

The aim is to investigate rapid antimicrobial susceptibility testing directly from positive blood cultures in patients with sepsis.
Randomized trial conducted on patients with bloodstream infections
Antimicrobial susceptibility testing performed directly on positive blood cultures
Analysis of patient outcomes based on rapid test results
Rapid susceptibility testing reduced the time to effective antibiotic therapy by 24 hours (p<0.01)
Mortality rate decreased by 15% in patients receiving early targeted therapy (HR 0.85, 95% CI 0.75-0.95, p=0.03)
Length of hospital stay reduced by an average of 3 days in the intervention group (p<0.05)

No takes yet. Share an insight, caveat, or question.

Randomized trial evaluates antimicrobial susceptibility testing outcomes in sepsis, suggesting improved patient management.

Osaid et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark